Obese mice given MOTS-c injections for three days had lower blood sugar levels than mice that didn't receive the treatment.

8

Pro

0

Against

Evidence from Studies

Supporting (1)

8

Community contributions welcome

8

The mitochondrial‐derived peptide MOTS‐c is a regulator of plasma metabolites and enhances insulin sensitivity

Cohort Study

Animal

2019 Jul

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Source Study

The mitochondrial‐derived peptide MOTS‐c is a regulator of plasma metabolites and enhances insulin sensitivity

Score: 8

DOI: 10.14814/phy2.14171

Similar Assertions

Obese mice given MOTS-c had lower levels of suberate, a dicarboxylic acid, by 40% compared to untreated mice.

8

0

86%

MOTS-c injections in obese mice reduced a type of fat molecule called 2-oleoylglycerol by about 32% compared to untreated mice.

8

0

82%

Mice that ate a fatty diet and got daily MOTS-c shots didn’t get as fat as mice that didn’t get the shots—even though they ate the same amount of food.

13

0

82%

Diabetic rats given MOTS-c had lower blood sugar levels after fasting, showing better control of glucose.

14

0

80%

MOTS-c injections in obese mice lowered sebacate, a dicarboxylic acid, by 42% compared to untreated mice.

8

0

78%